Twist Bioscience Corp achieved record Revenue of $118.4 million for the fiscal third quarter, reflecting a 23% jump compared to the previous year. The company’s updated FY 2026 guidance indicates strong growth momentum, which may attract investor interest as it aims for breakeven adjusted EBITDA.
Key Highlights
- Twist Bioscience Corp ( Nasdaq : TWST) reported exceptional results for its fiscal third quarter, achieving revenue of $118.4 million.
- For the third quarter of fiscal 2026, Twist Bioscience saw its revenue climb by 23% year-over-year, marking 14 consecutive quarters of growth.
- Revised Upward Twist has raised its full-year revenue guidance to a range of $456 to $457 million, an increase of $12 million from earlier projections.
Twist Bioscience Corp (NASDAQ: TWST) reported exceptional results for its fiscal third quarter, achieving revenue of $118.4 million. This represents a more than 23% increase compared to $96.1 million in the same quarter last year. The performance comes amidst heightened investor interest, given that TWST shares have surged 182.6% year-to-date, although they have dipped by 10.5% in the past month.
Record Revenue Growth
For the third quarter of fiscal 2026, Twist Bioscience saw its revenue climb by 23% year-over-year, marking 14 consecutive quarters of growth. The DNA Synthesis and Protein Solutions (DSPS) segment was particularly strong, reporting a notable 39% increase to $56.6 million, while revenue from NGS Applications rose 12% to $61.8 million. This steady increase reflects ongoing Demand in the biotech sector as Twist ramps up production capabilities and broadens its product offerings.
The company maintains a market Capitalization of about $5.7 billion, positioning it strongly within the market.
Guidance
Revised Upward Twist has raised its full-year revenue guidance to a range of $456 to $457 million, an increase of $12 million from earlier projections. For the upcoming fourth quarter, it anticipates approximately $123 million to $124 million in revenue, indicating about 25% year-over-year growth. This upward revision signals management's confidence in sustained demand across its product lines, as well as operational efficiency improvements, particularly in its DSPS and NGS segments.
The company is also focusing on achieving adjusted EBITDA breakeven this quarter, a important milestone for future profitability.
Current Market Dynamics
Despite the impressive revenue growth, insider activity surfaced with executives selling $3,116,015 worth of stock across 12 transactions in the past 60 days. As of mid-July, short interest in TWST stood at a significant 23% of shares outstanding, with nearly 9.7 days needed to cover them at average trading Volume . These factors may influence investor sentiment as Market Participants gauge both the market's reaction to Earnings and the broader context influencing stock performance.
Future Catalysts
Investors will be closely watching the upcoming Earnings Call scheduled for today at 8:00 a.m. ET, expecting insights on further growth strategies and operational metrics. The company’s outlook reflects a commitment to achieving financial stability while maintaining innovation in its product offerings. Market participants hope to gain clarity on how Twist plans to navigate potential challenges as it positions itself for year-over-year growth into fiscal 2027.
Analysis based on the Form 8-K filed 3 August 2026; figures verified against the filing and live market data.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making Investment decisions.






Please wait processing your request...